EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease

Alexander V Blagov, Varvara A Orekhova, Vasily N Sukhorukov iD, Alexandra A Melnichenko, Alexander N Orekhov iD

Pharmaceuticals · 14.08.2023 · 16 (8) · 1150

DOI: 10.3390/ph16081150 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 14.08.2023. Verfasst von Alexander V Blagov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, Moscow 125315, Russia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since inflammatory bowel diseases (IBDs) are chronic, the development of new effective therapeutics to combat them does not lose relevance. Oxidative stress is one of the main pathological processes that determines the progression of IBD. In this regard, antioxidant therapy seems to be a promising approach. The role of oxidative stress in the development and progression of IBD is considered in detail in this review. The main cause of oxidative stress in IBD is an inadequate response of leukocytes to dysbiosis and food components in the intestine. Passage of immune cells through the intestinal barrier leads to increased ROS concentration and the pathological consequences of exposure to oxidative stress based on the development of inflammation and impaired intestinal permeability. To combat oxidative stress in IBD, several promising natural (curcumin, resveratrol, quercetin, and melatonin) and artificial antioxidants (N-acetylcysteine (NAC) and artificial superoxide dismutase (aSOD)) that had been shown to be effective in a number of clinical trials have been proposed. Their mechanisms of action on pathological events in IBD and clinical manifestations from their impact have been determined. The prospects for the use of other antioxidants that have not yet been tested in the treatment of IBD, but have the properties of potential therapeutic candidates, have been also considered.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s diseaseIBDROSoxidative stressulcerative colitis

Autor:innen und Institutionen

  • Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, Moscow 125315, Russia.
  • Institute for Atherosclerosis Research, Osennyaya Street 4-1-207, Moscow 121609, Russia.

ORCID-Profile: Vasily N Sukhorukov, Alexander N Orekhov

Förderung

  • Russian Science Foundation

Zitieren

APA

Blagov, A. V., Orekhova, V. A., Sukhorukov, V. N., Melnichenko, A. A., & Orekhov, A. N. (2023). Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease. Pharmaceuticals, 16(8), 1150. https://doi.org/10.3390/ph16081150

Vancouver

Blagov AV, Orekhova VA, Sukhorukov VN, Melnichenko AA, Orekhov AN. Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease. Pharmaceuticals. 2023;16(8):1150. doi:10.3390/ph16081150

BibTeX
@article{Blagov2023,
  author = {Blagov, Alexander V and Orekhova, Varvara A and Sukhorukov, Vasily N and Melnichenko, Alexandra A and Orekhov, Alexander N},
  title = {Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {8},
  pages = {1150},
  doi = {10.3390/ph16081150}
}
Kostenlos starten →